Familial Alzheimer disease of early onset

A form of Parkinson disease with age of onset between 21 and 45 years, rigidity, painful cramps followed by tremor, bradykinesia, dystonia, gait complaints, falls and other non-motor symptoms. A slow disease progression and a more pronounced response

Alzheimer's disease with early onset

Dementia in Alzheimer's disease with early onset (G30.0+)

Early-onset Lafora body disease

Definition: Dementia in Alzheimer's disease with onset before the age of 65, with a relatively rapid deteriorating course and with marked multiple disorders of the higher cortical functions. | Alzheimer's disease, type 2 Presenile dementia, Alzheimer's type Primary degenerative dementia of the Alzheimer's type, presenile onset

5. Calls on the EU and its Member States to scale up primary prevention of, research into and early diagnosis and management of the four most common NCDs, i.e. cardiovascular diseases, respiratory diseases, cancer and diabetes, without neglecting other important NCDs, such as mental and neurological disorders, including Alzheimer's disease; emphasises the importance of the early identification of individuals who are at high risk of contracting or dying from these diseases or are suffering from pre-existing dispositions, chronic and severe illnesses and risk factors that aggravate NCDs;

5. Calls on the EU and its Member States to scale up primary prevention of, research into and early diagnosis and management of the four most common NCDs, i.e. cardiovascular diseases, respiratory diseases, cancer and diabetes, without neglecting other important NCDs, such as mental and neurological disorders, including Alzheimer's disease; emphasises the importance of the early identification of individuals who are at high risk of contracting or dying from these diseases or are suffering from pre-existing dispositions, chronic and severe illnesses and risk factors that aggravate NCDs;

13. Is convinced that the early diagnosis tests recently proposed by the International Working Group on the New Criteria for Alzheimer's Disease, research into risk factors and the definition of early-diagnosis criteria are vitally important;

14. Encourages all the Member States to engage actively in the definition, development and implementation of common protocols for early diagnosis, to establish biomarkers with a view to building on the emergence of new therapies for both dementia and pre-dementia, and to define a common research agenda in the field of neurodegenerative diseases and the sharing of best practices in the area of research into neurodegenerative diseases, thus reducing the prevailing inequalities between Member States and within Member States as regards diagnosis and treatment; points out that standard operational procedures for the assessment of disease markers will be key to drug discovery and to the development of more effective, technology-assisted care of pati ...[+++]ents with Alzheimer's disease;